Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$27,000.00
Use and Safety of Gaba Analogues in Patients with Chronic Kidney Disease and on Dialysis in Manitoba
FY 2024-25
Summary
Many patients on dialysis suffer severe itching symptoms which can cause a lot of difficulties in their lives and relationships. Standard treatments for itch include a medication called gabapentin. This medication is effective but recent studies have shown that there may be a high rate of dangerous side effects. The objective of my study is to understand how often gabapentin is used in patients with kidney failure and how often this use leads to serious side effects or hospital visits. This information will help patients and their doctors understand if the risks of gabapentin are worth the side effects in their case.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
563432
Name
Saul Sakshi
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Use and Safety of Gaba Analogues in Patients with Chronic Kidney Disease and on Dialysis in Manitoba
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adverse Events; Chronic Kidney Disease Associated Pruritus; Dialysis; Pruritus; Renal; Retrospective Cohort Study
Abstract
Many patients on dialysis suffer severe itching symptoms which can cause a lot of difficulties in their lives and relationships. Standard treatments for itch include a medication called gabapentin. This medication is effective but recent studies have shown that there may be a high rate of dangerous side effects. The objective of my study is to understand how often gabapentin is used in patients with kidney failure and how often this use leads to serious side effects or hospital visits. This information will help patients and their doctors understand if the risks of gabapentin are worth the side effects in their case.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Saul, Sakshi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~